INDIVIDUALS with joint pain or arthritis have almost proverbially associated weather conditions with varying levels of pain. However, research undertaken…

TODAY, the average American is twice as likely to be diagnosed with knee osteoarthritis than in the years leading up to World War II, according to a…

United Kingdom, August 31, 2017: Welcome to this year’s third instalment of the European Medical Journal. This issue contains an abundance of…

Myelofibrosis (MF), either primary or secondary to polycythaemia vera or essential thrombocythaemia, is the most symptomatic and has the worst prognosis…

Hypereosinophilic syndromes are a group of disorders characterised by significant eosinophilia and organ damage.

Patients with refractory/relapsed (R/R) non-Hodgkin lymphoma (NHL) make up a very heterogeneous population with a poor life expectancy.

The objective of the symposium was to provide an overview of the current treatment landscape in terms of later-line therapy in metastatic CRC (mCRC) and to discuss the evidence for the various options available.

The main objectives of the symposium were to explore the current developments in the diagnosis and treatment of non-Hodgkin lymphoma (NHL).

Multiple myeloma (MM) is a plasma cell disorder that represents almost 10% of haematologic malignancies.